NCT06605404 - Pan-tumor MRD Study | Biotech Hunter

Enrollment

1,350

Participants

Timeline

Start Date

January 8, 2025

Primary Completion Date

December 31, 2031

Study Completion Date

April 30, 2032

Conditions

Muscle Invasive Bladder Urothelial CarcinomaEsophageal CancerGastric and Gastroesophageal Junction (GEJ) AdenocarcinomaMelanoma (Skin Cancer)NSCLC (Non-small Cell Lung Cancer)Pancreatic (Exocrine Only)Mix of Solid Tumors (MOST)

Interventions

DIAGNOSTIC_TEST

blood and tissue samples

routine standard of care

OTHER

blood and tissue samples

Routine standard of care

Trial Locations (2)

43437

RECRUITING

Taylor Cancer Research Center, Maumee

92123

RECRUITING

Medical Oncology Associates of San Diego, San Diego